Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
This Pharmaceutical Company Is A Better Pick Over Johnson & Johnson Stock
06:00am, Wednesday, 23'rd Nov 2022
While ABBV may outperform JNJ in the next three years, it is helpful to see how Johnson & Johnson's Peers fare on metrics that matter.
AbbVie Boosts Its Dividend: Is the Dividend King a Buy?
05:20am, Wednesday, 23'rd Nov 2022
Shares of the pharmaceutical stock have left the S&P 500 index in the dust so far this year.
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
09:45am, Tuesday, 22'nd Nov 2022
The pharmaceutical company's golden goose is about to stop laying golden eggs, but that won't be a permanent problem.
AbbVie to Present at the Piper Sandler Healthcare Conference
09:00am, Tuesday, 22'nd Nov 2022
NORTH CHICAGO, Ill. , Nov. 22, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Piper Sandler 34th Annual Healthcare Conference on Thursday, December 1, 2022.
AbbVie (ABBV) BLA for Epcoritamab Gets FDA Priority Tag
07:32am, Tuesday, 22'nd Nov 2022
The FDA grants priority review status to AbbVie's (ABBV) BLA for epcoritamab for the relapsed/refractory large B-cell lymphoma (LBCL), a form of NHL.
Want Passive Income in 2023? Buy These Dividend Kings
06:00am, Tuesday, 22'nd Nov 2022
These stocks offer you a gift: recurrent income just for owning them.
AbbVie: Paid To Wait
04:05am, Tuesday, 22'nd Nov 2022
AbbVie is a global biopharmaceutical company with a large portfolio of drugs and therapies. Its most successful drug, Humira, is facing a loss of exclusivity in 2023.
9 Best Value Stocks to Buy Now
01:20pm, Wednesday, 16'th Nov 2022
A roller-coaster year has sent a lot of deserving names into bargain territory. Here are nine value stocks for investors to consider as we head into 2023.
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
08:11am, Wednesday, 16'th Nov 2022
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry.
AbbVie Inc. (ABBV) Presents at 4th Annual Wolfe Research Healthcare Conference
02:03pm, Tuesday, 15'th Nov 2022
AbbVie Inc.
3 Pharmaceutical Stocks For Your November 2022 Watchlist
01:00pm, Tuesday, 15'th Nov 2022
3 pharmaceutical stocks to watch in the stock market right now.
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
10:32am, Monday, 14'th Nov 2022
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
2 Top Stocks to Buy in November and Hold Forever
06:00am, Sunday, 13'th Nov 2022
Today is a great time to enter these long-term stories.
7 No-Brainer Dividend Stocks to Buy for 2023 and Beyond
12:59pm, Thursday, 10'th Nov 2022
With the monetary paradigm shifting beneath our feet, investors have every reason to consider no-brainer dividend stocks to buy for 2023 and beyond. This is no marketing gimmick – folks need to avoi
If You Like Dividends, You Should Love These 3 Stocks
10:05am, Wednesday, 09'th Nov 2022
These stocks are crushing the market this year and still have tremendous profit potential.
